BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 23557674)

  • 1. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
    Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
    Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine re-challenge under the cover of Filgrastim.
    Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
    J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clozapine rechallenge after neutropenia in resistant schizophrenia: A review].
    Simon L; Cazard F
    Encephale; 2016 Aug; 42(4):346-53. PubMed ID: 27109327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G; Yeh HS
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neutropenia in a patient treated with clozapine in combination with other psychotropic drugs].
    Sénéchal A; Landry P; Deschamps R; Lessard M
    Encephale; 2002; 28(6 Pt 1):567-9. PubMed ID: 12506270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
    Hazewinkel AW; Bogers JP; Giltay EJ
    Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
    Myles N; Myles H; Clark SR; Bird R; Siskind D
    Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N; Gee S; Whiskey E; Taylor D; Mijovic A; Gaughran F; Shergill S; MacCabe JH
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
    Kolli V; Denton K; Borra D; Pulluri M; Sharma A
    Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythm of neutrophil counts and granulocyte macrophage-colony stimulating factor (GM-CSF) under clozapine treatment: a case report.
    Ferrea S; Fehsel K; Cordes J; Luckhaus C
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):511-3. PubMed ID: 19396726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G; Eskelinen S; Sailas E
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
    Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
    J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.
    Geibig CB; Marks LW
    Ann Pharmacother; 1993 Oct; 27(10):1190-4. PubMed ID: 7504534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report.
    Spencer BW; Williams HR; Gee SH; Whiskey E; Rodrigues JP; Mijovic A; MacCabe JH
    J Psychopharmacol; 2012 Sep; 26(9):1280-2. PubMed ID: 22719015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG; Stewart JT
    South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine XR-induced neutropenia: is a clozapine trial still possible for treatment-resistant schizophrenia? A case report.
    Crépeau-Gendron G; L'Heureux S
    Early Interv Psychiatry; 2015 Apr; 9(2):151-5. PubMed ID: 24690066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor G-CSF].
    Heinz P; Müller H; Bauer M
    Psychiatr Prax; 1994 Mar; 21(2):81. PubMed ID: 7515190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.